DekaBank Deutsche Girozentrale’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-59,600
| Closed | -$493K | – | 1251 |
|
|
2023
Q1 | $493K | Hold |
59,600
| – | – | ﹤0.01% | 1011 |
|
|
2022
Q4 | $444K | Hold |
59,600
| – | – | ﹤0.01% | 1063 |
|
|
2022
Q3 | $400K | Hold |
59,600
| – | – | ﹤0.01% | 1086 |
|
|
2022
Q2 | $480K | Hold |
59,600
| – | – | ﹤0.01% | 1026 |
|
|
2022
Q1 | $827K | Buy |
59,600
+5,400
| +10% | +$74.9K | ﹤0.01% | 950 |
|
|
2021
Q4 | $1.41M | Buy |
54,200
+11,200
| +26% | +$292K | ﹤0.01% | 858 |
|
|
2021
Q3 | $1.4M | Hold |
43,000
| – | – | ﹤0.01% | 817 |
|
|
2021
Q2 | $1.8M | Hold |
43,000
| – | – | 0.01% | 749 |
|
|
2021
Q1 | $1.63M | Hold |
43,000
| – | – | 0.01% | 758 |
|
|
2020
Q4 | $2.54M | Buy |
43,000
+2,900
| +7% | +$171K | 0.01% | 613 |
|
|
2020
Q3 | $1.9M | Buy |
+40,100
| New | +$1.9M | 0.01% | 597 |
|